Posts in category Stock News


Genocea Biosciences Inc (GNCA) Investors Run for the Hills; Here’s Why

Genocea shares are plunging on termination of genital herpes treatment GEN-003.

Read more

Here’s Why Red Hat Inc (RHT) Shares Have Popped to Another Record

Red Hat’s F2Q18 results significantly beat on revenue, margin and EPS.

Read more

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Announces Relaunch of Generic Depo-Provera in the US

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the reintroduction of the generic equivalent to Depo-Provera®1 …

Read more

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety …

Read more

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and HLS Therapeutics Announce Agreement to Commercialize Vascepa in Canada

Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement …

Read more

Gilead Sciences, Inc. (GILD) Obtains CFDA Approval for Sovaldi for Treatment of Chronic Hepatitis C Virus Infection

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the China Food and Drug Administration (CFDA) has approved …

Read more

Intercept Pharmaceuticals Inc (ICPT) Comments on Ocaliva Safety and Dosing

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare …

Read more

Company Update (NASDAQ:IZEA): Izea Inc Announces Artificial Intelligence CurationEngine

Izea Inc (NASDAQ:IZEA) announced the release of CurationEngine™. The new system provides programmatic analysis and …

Read more

Company Update (NASDAQ:ORIG): Ocean Rig UDW Inc. Announces the Completion of Its Restructuring

Ocean Rig UDW Inc. (NASDAQ:ORIG) announced that the Scheme Conditions under the schemes of arrangement in …

Read more

Ascendis Pharma A/S (ASND) Shares Jump on the Back of Competitor’s Clinical Setback

Investors are snapping up Ascendis Pharma A/S (NASDAQ:ASND) shares following the news that competitor somavaratan …

Read more